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We examined interethnic differences in the prevalence of neuroimaging markers of cerebrovascular 
and neurodegenerative disease in 3 major Asian ethnicities (Chinese, Malays, and Indians), as well as 
their role in cognitive impairment. 3T MRI brain scans were acquired from 792 subjects (mean age: 
70.0 ± 6.5years, 52.1% women) in the multi-ethnic Epidemiology of Dementia In Singapore study. 
Markers of cerebrovascular disease and neurodegeneration were identified. Cognitive performance was 
evaluated using Mini Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and 
a neuropsychological assessment. Compared to Chinese, Malays had a higher burden of intracranial 
stenosis (OR: 2.28. 95%CI: 1.23–4.20) and cortical atrophy (β: −0.60. 95%CI: −0.78, −0.41), while 
Indians had a higher burden of subcortical atrophy (β: −0.23. 95%CI: −0.40, −0.06). Moreover, Malay 
and Indian ethnicities were likely to be cognitively impaired (OR for Malays: 3.79. 95%CI: 2.29–6.26; 
OR for Indians: 2.87. 95%CI: 1.74–4.74) and showed worse performance in global cognition (β for 
Malays: −0.51. 95%CI: −0.66, −0.37; and Indians: −0.32. 95%CI: −0.47, −0.17). A higher burden of 
cerebrovascular and neurodegenerative markers were found in Malays and Indians when compared 
to Chinese. Further research is required to fully elucidate the factors and pathways that contribute to 
these observed differences.
Dementia is a major public health concern as it is one of the leading causes of morbidity, disability and institu-
tionalization in the elderly worldwide, affecting up to 33.2% of individuals over the age of 85 years1. Concomitant 
with the trend of rapid demographic aging across major world regions, the number of affected individuals has 
been projected to further increase globally from 47 million in 2015 to 75 million by 2030 and 135 million by 
20502. Asia, as the most populous region in the world, is set to be the greatest contributor. The number of elderly 
in Asia is expected to increase from 414 million (10%) in 2010 to 829 million (17%) and 1.2 billion (24%) in 2030 
and 2050, respectively3.
Cerebrovascular disease and neurodegeneration are the two most dominant pathological processes implicated 
in vascular dementia (VaD) and Alzheimer’s disease (AD)4. Recent evidence suggests the existence of synergistic 
interactions between these two processes that further aggravates existing AD pathology5. Traditional vascular risk 
factors such as hypertension, hyperlipidaemia, diabetes, smoking, as well as the Apolipoprotein E (ApoE) ɛ4 allele 
have been identified to play a major role in increasing the risk of dementia and cognitive decline4.
Notably, previous epidemiological studies have highlighted ethnicity as a major determinant for demen-
tia6. It is suggested that overall dementia prevalence as well as that of subtypes of dementia were found to vary 
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substantially across different ethnic groups and geographical regions7,8. Higher rates of dementia, for example, 
have been found in African-Americans and Hispanics as compared to Caucasians9, and early reports have noted 
an excess burden of VaD over AD in Asian populations, as compared to Caucasians populations where AD is the 
dominant subtype3. These differences in dementia prevalence rates have been attributed to different susceptibility 
to pathological brain changes. Compared to Caucasians, Hispanics and African-Americans were found to have a 
higher burden of white matter hyperintensities whereas Asians were found to have a higher prevalence of intrac-
ranial stenosis10,11. Moreover, when comparing the same brain lesions, white matter hyperintensities (WMH) and 
microbleeds were much more prevalent in Asians compared to Caucasians12,13.
Although differences in known vascular and genetic risk profiles may play a role in these observed disparities, 
additional factors may also contribute in increasing the risk of cognitive impairment and dementia. Previous 
studies have traditionally focused on investigating relationships between determinants and neurologic outcomes, 
but the intermediary pathways remain relatively poorly characterised from a neuro-epidemiologic standpoint. 
Further research is therefore required to elucidate novel risk factors and biomarkers, better characterise the mech-
anism of these diseases, as well as offer valuable insights into service planning and resource allocation. To this 
end, Singapore is an ideal setting for interethnic research, given its relatively homogenous environment, as well 
as a unique ethnic composition of Chinese, Malays and Indians representing the major ethnic groups across Asia.
The Epidemiology of Dementia in Singapore (EDIS) study is a subsample of a population-based study focus-
ing on the risk factors and prevalence of dementia and cognitive impairment in the three major Asian ethnici-
ties. Previously, we have reported a higher age-standardized prevalence of any cognitive impairment in Malays 
(25.5%) and Indians (24.6%) as compared to Chinese (15.2%)14–16. In the present study, we aim to examine how 
subclinical brain changes (characterized by a higher burden of cerebrovascular disease and neurodegeneration on 
neuroimaging) differ in three major ethnicities i.e. Chinese, Malays and Indians, and whether such differences, if 
any, may help explain differences in cognitive performance.
Methods
Study design and target population. The EDIS study employs a cross-sectional design drawing partici-
pants who were long-term local citizens from the Singapore Epidemiology of Eye Disease (SEED) study, consist-
ing of the Singapore Chinese Eye Study, Singapore Malay Eye Study-2, and the Singapore Indian Eye Study-2. In 
the first phase of the EDIS study, participants ≥60 years underwent cognitive screening using the Abbreviated 
Mental Test (AMT) and the Progressive Forgetfulness Questionnaire (Fig. 1). Screen positives were defined as: 
an AMT score of ≤6 for those who received ≤6 years of formal education, an AMT score of ≤8 for those who 
received >6 years of formal education, or if the caregiver reported a history of progressive forgetfulness. Screen 
positives who provided consent (n = 957) participated in the second phase of the study, which included compre-
hensive clinical and neuropsychological evaluations, together with neuroimaging at the same session. The final 
sample in the analysis (n = 792) excluded participants who were claustrophobic, unable to tolerate the procedure, 
had contraindications for magnetic resonance imaging (MRI), had ungradable scans, or missing demographic/
clinical data.
Ethics approval was obtained from the National Healthcare Group-specific Review Board and the Singapore 
Eye Research Institute. The study was conducted in accordance with the Declaration of Helsinki. Informed con-
sent was also obtained from the study participants in their preferred language.
Figure 1. Flow chart of participants in the Epidemiology of Dementia in Singapore (EDIS) Study. 
Abbreviations – Abbreviated Mental Test: AMT; Progressive Forgetfulness Questionnaire: PFQ.
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Demographic and cardiovascular risk factor assessment. Demographic and medical histories were 
obtained using a detailed questionnaire during an interview, which were further verified with medical records. 
Data collected included age, gender, ethnicity, smoking status, body mass index, history of hypertension, hyper-
lipidaemia and diabetes mellitus. Ethnic status of each participant was determined using their National Identity 
Cards which captures information on ethnicity from birth certificates. Two measurements of blood pressure were 
taken in 5 minute intervals following an initial rest period of 5 minutes. Hypertension was defined as a systolic 
blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg, or the use of anti-hypertensive med-
ication. Diabetes mellitus was defined as a glycated hemoglobin ≥6.5%, or the use of anti-diabetic medication. 
Hyperlipidemia was defined as a total cholesterol level ≥4.14 mmol/l, or the use of lipid-lowering medication. A 
positive smoking status was defined as ever having smoked previously. Heart diseases included ischemic heart 
disease, congestive heart failure, atrial fibrillation, and cardiac bypass. Genome-wide genotyping was performed 
using the Illumina Human610-Quad BeadChip with the 1000 Genomes (phase 1, version 3) reference panel used 
for imputation as described previously14. Imputed data on two single nucleotide polymorphisms (SNP) [rs429358 
and rs7412] was used to define ApoE status.
Cognitive assessment and clinical diagnoses. Cognitive function was assessed using the Mini-Mental 
State Examination (MMSE), Montreal Cognitive Assessment (MoCA), as well as an extensive neuropsychologi-
cal battery in participant’s native language or most fluently spoken language16–18. From these cognitive tests, the 
following seven domains (five non-memory and two memory) were examined:
•	 Executive function using the Frontal Assessment Battery and Maze Task
•	 Attention using the Digit Span, Visual Memory Span and Auditory Detection
•	 Language using the Boston Naming Test and Verbal Fluency Test
•	 Visuomotor speed using the Symbol Digit Modality Test and Digit Cancellation Test
•	 Visuoconstruction using the Wechsler Memory Scale–Revised, Visual Reproduction Copy task, Clock Draw-
ing, and Wechsler Adult Intelligence Scale–Revised subtest of Block Design
•	 Verbal Memory using the Word List Recall and Story Recall
•	 Visual Memory using the Picture Recall and Wechsler Memory Scale–Revised Visual Reproduction Tests
Using these data, we calculated domain-specific and composite Z-scores based on previously established 
methodology17. For each individual test within a domain raw scores were first transformed to standardized 
Z-scores using the mean and standard deviation [SD] of that test in this cohort. Subsequently, for each domain a 
mean Z-score was calculated by taking the average Z-scores of all the individual tests within that domain. These 
domain-specific mean Z-scores were then standardized using the mean and SD within that domain. Finally, a 
composite Z-score was computed by averaging the seven domain-specific mean Z-scores, which were also stand-
ardized using the corresponding mean and SD17. This composite Z-score reflected global cognitive functioning.
Cognitive impairment no dementia (CIND) was defined as impairment in one or more domains of the neu-
ropsychological battery, without significant loss of independence in daily activities. Participants were considered 
to have failed a test if they scored 1.5 SD below education-adjusted cut-off values on an individual test. Failure in 
at least half of the tests in a domain was considered as impairment in that domain. Impairment in ≤2 domains 
was classified as CIND mild while >2 was classified as CIND moderate as described previously16. The diagnosis 
of dementia was made according to the DSM-IV criteria. Any cognitive impairment was a combination of CIND 
mild, moderate and dementia.
Neuroimaging. Neuroimaging was performed at the Clinical Imaging Research Centre, National University 
of Singapore with a 3 T Siemens Magnetom Trio Tim scanner using a 32-channel head coil (Siemens Healthcare, 
Erlangen, Germany). All the images were assessed for the following biomarkers:
•	 Cortical infarcts were identified as focal lesions involving cortical gray matter with hyperintense rim on 
FLAIR images, with a centre similar to cerebrospinal fluid intensity, loss of tissue of variable magnitude, as 
well as prominent adjacent sulci and ipsilateral ventricular enlargement.
•	 Lacunar infarcts were defined as subcortical lesions, 3 to 15 mm in diameter, hyperintense on T2-weighted 
images, hypointense on FLAIR and T1-weighted images but with a hyperintense rim on FLAIR.
•	 Cerebral microbleeds were defined as focal rounded lesions of hypointensity on susceptibility-weighted 
images with a blooming effect, and were graded using the Brain Observer Microbleed Scale.
•	 Cortical microinfarcts were defined as cortical lesions of 5 mm or less in diameter, perpendicular to the cor-
tical surface, hypointense on T1-weighted images, hyperintense on T2-weighted images and hyperintense or 
isointense on FLAIR images19.
•	 Intracranial stenosis was defined as the narrowing of 50% or more in the internal carotid, vertebral, basilar, 
posterior cerebral, middle cerebral, and/or anterior cerebral arteries using magnetic resonance angiography19.
Quantitative MRI data were obtained using automatic segmentation at the Department of Medical Informatics 
and the Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, The Netherlands.
•	 Cortical thickness was measured using FreeSurfer (v.5.1) and was defined as the shortest distance between 
white matter/gray matter boundary and pial surface and measured on T1-weighted images20.
•	 Volumes of subcortical structures (accumbens, amygdala, caudate, pallidum, putamen, thalamus, hip-
pocampus and brainstem) were segmented using a model-based, automated procedure (FreeSurfer, v.5.1) on 
T1-weighted images21.
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•	 Image preprocessing and the tissue classification algorithm have been described elsewhere19. Briefly, k-near-
est-neighbor brain tissue classifier technique was used to classify voxels into cerebrospinal fluid, gray matter, 
normal white matter, WMH, and volume (ml) was calculated from these measurements. Intracranial volume 
was the sum of the cerebrospinal fluid, gray matter, normal white matter and WMH.
Statistical analysis. Continuous variables were summarized by their means and standard deviations except 
for WMH, which was summarized by its median and interquartile range due to a skewed distribution. Categorical 
variables were summarized using counts and percentages. Global cognitive function was reflected by a composite 
Z-score derived from the scores in various domains of the neuropsychological battery based on previously estab-
lished methodology19. For each individual test within a domain raw scores were first transformed to standardized 
Z-scores using the mean and standard deviation [SD] of that test in this cohort. Subsequently, for each domain a 
mean Z-score was calculated by taking the average Z-scores of all the individual tests within that domain. These 
domain-specific mean Z-scores were then standardized using the mean and SD within that domain. Finally, a 
composite Z-score was computed by averaging the seven domain-specific mean Z-scores, which were also stand-
ardized using the corresponding mean and SD19. This composite Z-score reflected global cognitive functioning. 
To assess whether characteristics between ethnicities were different, the following tests were used: chi-square 
test for categorical variables, analysis of variance (ANOVA) for continuous variables, and Kruskal-Wallis test for 
WMH. When there is evidence of differences, pairwise comparisons were made while accounting for multiple 
testing with Bonferroni correction, where the following tests were used: chi-square test for categorical variables, 
t-test for continuous variables, and Wilcoxon signed rank test for WMH. In the regression analyses, continuous 
variables were standardized with mean differences (MD) expressed as per standard deviation increase or decrease, 
except for WMH, which was log-transformed. To examine associations between ethnicity with cerebrovascular 
and neurodegenerative markers as well as with cognitive outcomes, odds ratios (OR) and mean differences were 
computed with 95% confidence intervals (CI) by using logistic and linear regression models. These models were 
initially adjusted for demographic and vascular risk factors and additionally for intracranial volume in models for 
WMH, cortical thickness and subcortical structures. To account for multiple testing in the comparison of each 
neuroimaging marker across ethnicities (i.e. three pairwise comparisons), Bonferroni-correction was applied for 
an adjusted α-value of 0.05/3 = 0.017. Subjects with cortical infarcts (n = 26) were excluded from the analysis of 
WMH due to the possibility that large cortical infarcts may affect the measurement of WMH. All statistical anal-
yses were performed using IBM SPSS Statistics Version 23.
Results
Supplementary Table 1 presents the characteristics of the included (n = 792) and excluded (n = 806) persons. The 
excluded group consisted of screened positive non-responders, persons with ungradable MRI scans, or missing 
demographic/clinical data. Briefly, excluded individuals were older, more likely to be female, less educated and 
have hypertension and less likely to have hyperlipidemia. The characteristics of the study population are pre-
sented in Table 1. A total of 792 participants were included in the final analysis, comprising of 262 Chinese, 276 
Malays, and 254 Indians. Compared to Chinese and Malays, Indians were relatively younger with higher level 
of education. With respect to vascular risk factors, Chinese had lower body mass index (BMI) as well as a lower 
prevalence of heart disease compared to Malays and Indians. Indians on the other hand had a lower prevalence 
of hypertension, but a higher prevalence of hyperlipidaemia and diabetes compared to the other two ethnicities. 
Prevalence of ApoE ɛ4 carriers was the highest in Malays. Among neuroimaging markers, no significant differ-
ences were observed in the prevalence of infarcts; however, cerebral microbleeds, cortical microinfarcts, and 
intracranial stenosis appeared to be more prevalent in Malays as compared to Chinese and Indians. A decreasing 
trend in total intracranial volumes was observed from Chinese to Malays to Indians. Malays had more global 
cortical thinning on average, while Indians had smallest subcortical structure volume.
The prevalence of any cognitive impairment was lowest in Chinese, i.e. 56.1% (95%CI: 50.1–61.9), as com-
pared to Malays and Indians at 81.5% (95%CI: 76.5–85.6) and 70.5% (95%CI: 64.6–75.7). Mean score on MMSE 
for Chinese, Malays and Indians were 24.6, 22.2, and 24.3 whereas that for MoCA was 20.7, 16.6, and 19.9 
respectively.
Table 2 shows the interethnic differences in neuroimaging markers, after adjusting for demographic and vas-
cular risk factors. Malays had a significantly higher burden of intracranial stenosis compared to both Chinese 
(OR: 2.28. 95% CI: 1.23–4.20) and Indians (OR: 3.77. 95% CI: 1.90–7.48), while no significant differences were 
observed in cerebrovascular disease markers between Chinese and Indians. Patterns of markers for neurodegen-
eration differed across all three ethnicities - Malays were more likely to have smaller cortical thickness (mean 
difference for Malays compared to Chinese: −0.60, 95% CI: −0.78, −0.41; mean difference for Malays compared 
to Indians: −0.39, 95% CI: −0.58, −0.20) while Indians were more likely to have smaller subcortical structure 
volumes (mean difference for Indians compared to Chinese: −0.23, 95% CI: −0.40, −0.06).
Additional logistic regression models were then constructed to assess the association between ethnicity and 
cognitive outcomes. Both Malay and Indian ethnicities were found to be associated with higher odds for cognitive 
impairment (OR for Malays: 3.79. 95% CI: 2.29–6.26; OR for Indians: 2.87. 95% CI: 1.74–4.74), as well as lower 
scores for MMSE (mean difference for Malays: −2.27. 95% CI: −2.97, −1.58; mean difference for Indians: −1.56. 
95% CI: −2.30, −0.81), MoCA (mean difference for Malays: −3.48. 95% CI: −4.36, −2.61; mean difference for 
Indians: −2.27. 95% CI: −3.21, −1.33) and global cognition (mean difference for Malays: −0.51. 95% CI: −0.66, 
−0.37; mean difference for Indians: −0.32. 95% CI: −0.47, −0.17) when compared with Chinese ethnicity, inde-
pendent of demographic and vascular risk factors. These associations were attenuated upon further adjustments 
for markers of cerebrovascular disease and neurodegeneration, but remained significant (Table 3 and Fig. 2).
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Discussion
In this study, we report a higher prevalence of cerebrovascular disease and neurodegeneration in Malays and 
Indians, as compared to Chinese. Specifically, Malay ethnicity was associated with intracranial stenosis and 
cortical atrophy, whereas Indian ethnicity was associated with subcortical atrophy. Furthermore, both Malay 
and Indian ethnicities were more likely to be cognitively impaired and showed worse cognitive performance. 
Strengths of the study include a population-based study with a relatively large sample size, use of an extensive 
neuropsychological test battery in assessing cognitive function, automated and standardized procedures in quan-
titative image analysis, as well as adjustments for a broad range of demographic and cardiovascular risk factors 
that could potentially confound associations between imaging markers and cognition.
Interethnic disparities in cerebrovascular disease among non-Asian populations have been well documented 
previously22. Differences in stroke aetiologies were found among patients in the South London Ethnicity and 
Stroke Study, where strokes secondary to cerebral small vessel disease were more prevalent in Blacks as compared 
to Whites23. Blacks and Hispanics were also reported to have an increased risk for intracranial stenosis, stroke, 
as well as WMH11,24,25. In a population from New Zealand, patients of Maori and Pacific origins were similarly 
found to have an increased risk of stroke than those of European origin26. Additionally, increased prevalence of 
confluent WMH and microbleeds have also been identified in Chinese and Blacks respectively, when compared 
to Caucasians12,27. In the context of Asian populations, the burden of cerebrovascular disease has been previously 
reported to be higher compared to Caucasian13. Two Chinese studies have previously reported the prevalence of 
intracranial stenosis at 6.9% in subjects ≥40 years, and of middle cerebral artery stenosis at 5.9% in subjects ≥50 
years28. Comparison within the three ethnicities in our study showed a higher burden of intracranial stenosis in 
Malays when compared to Chinese and Indians, which may be attributed to increased plaque deposition and 
atherosclerosis.
Interethnic differences in neurodegenerative markers as measured on MRI, are less well established in pre-
clinical stages of dementia. Thus far, studies examining differences in the prevalence of AD have yielded clear 
interethnic disparities. A twofold increase in the incidence of AD has been found in African-American and 
Caribbean Hispanic individuals as compared to Whites9,29. Similarly, a study in India using a comparative meth-
odology to US population also found a substantial difference in the rate of AD in those aged 65 years and older, 
at 4.7 per 1000 person-years compared to that of 17.5 per 1000 person-years in the US population30. However, 
investigations involving neuroimaging correlates of such findings are lacking. In the present study, we have iden-
tified a pattern of neurodegeneration, with increased cortical atrophy in Malays and increased subcortical atrophy 
in Indians, consistent with the increased rates of dementia in the corresponding ethnicities.
Ethnicity
Chinese
(n = 262)
Malays
(n = 276)
Indian
(n = 254) p-value
Demographics
Age, years, mean (SD) 70.3 (6.2)† 70.9 (6.9)‡ 68.7 (6.1)*‡ <0.001
Gender, female, n (%) 137 (52.3) 153 (55.4) 123 (48.4) 0.271
Education, years, mean (SD) 5.7 (4.9)*† 4.7 (3.6)†‡ 7.9 (4.4)*‡ <0.001
Vascular risk factors
BMI, kg/m2, mean (SD) 19.0 (2.8)*† 20.5 (4.0)‡ 21.0 (3.3)‡ <0.001
Smoking, n (%) 81 (30.9) 78 (28.3) 55 (21.7) 0.051
Heart disease, n (%) 9 (3.4)*† 23 (8.3)‡ 28 (11.0)‡ 0.004
Hypertension, n (%) 208 (79.4) 239 (86.6)‡ 191 (75.2)† 0.004
Hyperlipidemia, n (%) 158 (60.3)*† 225 (81.5)‡ 220 (86.6)‡ <0.001
Diabetes, n (%) 71 (27.1)† 91 (33.0)† 132 (52.0)*‡ <0.001
ApoE ɛ4 carrier, n (%) 27 (13.8)* 52 (24.2)‡ 31 (15.4) 0.012
Neuroimaging markers
Presence of any infarct, n (%) 46 (17.6) 65 (23.6) 43 (16.9) 0.101
Cortical infarcts, n (%) 7 (2.7) 9 (3.3) 10 (3.9) 0.722
Lacunes, n (%) 41 (15.6) 58 (21.0) 36 (14.2) 0.086
Presence of CMB, n (%) 84 (32.1) 113 (40.9)† 78 (30.7)* 0.026
Presence of CMI, n (%) 11 (4.2) 26 (9.4)‡ 9 (3.5)* 0.006
Presence of ICS, n (%) 27 (10.3)* 62 (22.5)†‡ 17 (6.7)* <0.001
WMH volume, ml, median (IQR) 1.9 (4.5)† 2.1 (6.8)† 0.9 (2.5)*‡ <0.001
Total intracranial volume, ml, mean (SD) 1092.2 (102.6)*† 1063.6 (106.2)†‡ 1027.8 (112.0)*‡ <0.001
Global cortical thickness, um, mean (SD) 2397.7 (97.9)* 2333.7 (108.9)†‡ 2380.0 (99.2)* <0.001
Global subcortical structure volume, mm3, mean (SD) 5914.9 (578.2)*† 5738.1 (609.1)‡ 5641.1 (561.6)‡ <0.001
Table 1. Characteristics of study population (n = 792), stratified by ethnicity. * - significantly different from 
Malays. † - significantly different from Indians. ‡ - significantly different from Chinese. Abbreviations – 
CMB: cerebral microbleeds; CMI: cortical microinfarcts; ICS: intracranial stenosis; WMH: white matter 
hyperintensities; CIND: cognitive impairment no dementia.
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Several reasons may underlie these observed interethnic disparities in cerebrovascular and neurodegenerative dis-
ease burden. Differences in demographic and cardiovascular risk factors are thought to be the predominant drivers for 
these differences—Malays and Indians in this regard were found to have a higher rate of cardiovascular disease than 
Chinese, and Malays also have the lowest educational attainment among the three ethnicities. However, adjusting for 
these traditional risk factors did not fully account for the interethnic differences in neuroimaging markers. This points 
to the potential role of other factors such as ApoE31, Apolipoprotein A-V32, and levels of C-reactive protein33, among 
others. Dietary habits, such as consumption of clarified fats in ghee, a staple ingredient of South-East Asian cuisine, 
has been linked to dyslipidaemia and thus increasing the risk of cerebrovascular disease.
In particular, ApoE ɛ4 allele has been demonstrated as one of the most important genetic risk factor for dementia 
in various population-based studies worldwide, and is notably associated with hippocampal atrophy34,35. Conversely, 
the ɛ2/ɛ3 alleles appear to exert a protective effect. Marked ethnic variance in ɛ4 allele frequencies has been noted—
ranging from 5% or less in the Amish to over 40% in some aboriginal populations36,37. Furthermore, some studies 
have identified variability in the effect of ApoE polymorphisms among ethnicities, with the stronger association 
between ɛ4 and AD in Japanese and weak to non-existent in African Americans and Hispanics38. A recent study has 
also reported that ɛ4 appears to mediate differential effects with regards to the levels of total tau and phosphorylated 
tau-181 in African Americans as compared to Whites, reflecting possible mechanisms of differing susceptibility to 
disease6. In the context of Singapore, the ɛ4 allele was previously found to be twice as common in Malays as com-
pared to Indians and Chinese; the ɛ2 allele was found to be rarest in Indians31. However, the interethnic differences 
noted in the current study were independent from the ɛ4 allele interaction, suggesting the influence of other factors.
Neuroimaging markers
Malays vs. Chinese
OR (95% CI)
Indians vs. Chinese
OR (95% CI)
Malays vs. Indians
OR (95% CI)
Overall
p-value
Cerebrovascular markers
Presence of any infarct 1.12 (0.65–1.95)p = 0.679
0.98 (0.54–1.80)
p = 0.961
1.14 (0.65–2.00)
p = 0.647 0.874
Cortical infarcts 0.62 (0.18–2.18)p = 0.459
1.20 (0.37–3.86)
p = 0.765
0.52 (0.15–1.78)
p = 0.300 0.572
Lacunes 1.20 (0.67–2.15)p = 0.538
0.96 (0.50–1.83)
p = 0.907
1.25 (0.69–2.27)
p = 0.468 0.722
WMH volume (log transformed)* 0.13 (−0.04, 0.30)p = 0.128
−0.05 (−0.23, 0.14)
p = 0.623
0.18 (0.00, 0.35)
p = 0.044 0.098
Presence of CMB 1.11 (0.73–1.70)p = 0.626
0.86 (0.54–1.36)
p = 0.509
1.30 (0.84–2.00)
p = 0.241 0.503
Presence of CMI 2.03 (0.83–4.98)p = 0.121
1.07 (0.37–3.12)
p = 0.899
1.90 (0.75–4.76)
p = 0.174 0.196
Presence of ICS 2.28 (1.23–4.20)p = 0.009
0.60 (0.27–1.33)
p = 0.211
3.77 (1.90–7.48)
p = < 0.001 <0.001
Neurodegenerative markers†
Global cortical thickness −0.60 (−0.78, −0.41)p = < 0.001
−0.20 (−0.41, 0.00)
p = 0.052
−0.39 (−0.58, 
−0.20)
p = < 0.001
<0.001
Global subcortical structure volume −0.12 (−0.27, 0.03)p = 0.123
−0.23 (−0.40, −0.06)
p = 0.008
0.11 (−0.05, 0.27)
p = 0.174 0.028
Table 2. Association of ethnicity with neuroimaging markers. Model is adjusted for age, gender, ApoE ɛ4 carrier 
status, smoking status, diabetes, hypertension, hyperlipidemia and BMI. Individual p-values are significant 
(bolded) at a Bonferroni-corrected α value of 0.05/3 = 0.017. Overall p-values are significant (italicised) at α = 0.05. 
* WMH volumes are log-transformed and additionally adjusted for total intracranial volume, with differences 
between ethnicities expressed in beta (95% CI) instead of odds ratio. † Neurodegenerative markers are additionally 
adjusted for total intracranial volume and expressed in beta (95% CI). Abbreviations – CMB: cerebral microbleeds; 
CMI: cortical microinfarcts; ICS: intracranial stenosis; WMH: white matter hyperintensities.
Diagnosis
Malays vs. Chinese
OR (95% CI)
Indians vs. Chinese
OR (95% CI)
Malays vs. Indians
OR (95% CI)
Overall 
p-value
CIND mild 3.04 (1.69–5.48)p = < 0.001
2.40 (1.32–4.38)
p = 0.004
1.27 (0.69–2.32)
p = 0.446 <0.001
CIND moderate/
dementia
4.66 (2.26–9.63)
p = < 0.001
2.27 (1.04–4.99)
p = 0.040
2.05 (0.94–4.49)
p = 0.073 <0.001
Any cognitive 
impairment
3.40 (1.99–5.81)
p = < 0.001
2.38 (1.38–4.11)
p = 0.002
1.43 (0.82–2.49)
p = 0.210 <0.001
Table 3. Association of ethnicities with cognitive impairment and dementia. Model is adjusted for age, 
gender, education, ApoE ɛ4 carrier status, smoking status, diabetes, hypertension, hyperlipidemia, BMI, and 
all neuroimaging markers. Individual p-values are significant (bolded) at a Bonferroni-corrected α value 
of 0.05/3 = 0.017. Overall p-values are significant (italicised) at α = 0.05. Abbreviations – CIND: cognitive 
impairment no dementia.
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A few studies have suggested differential effects of cerebrovascular disease and neurodegeneration on cog-
nition across ethnicities - beta amyloid deposition and WMH burden were found to be associated with faster 
cognitive decline and poorer performance in mean global cognition, language, and speed/executive functioning 
in African-Americans but not in Whites39. Our study adds further to the previous literature by reporting a higher 
odds for poorer cognitive outcomes in Malays and Indians which remained significant even after adjustment 
for cerebrovascular and neurodegenerative markers. There may be several reasons for this. Firstly, current neu-
roimaging modalities may not be sensitive enough in capturing the full extent of pathology, and that several 
undetected lesions might be a significant contributor to cognitive impairment. Secondly, differences in cognitive 
reserve in these ethnicities may also exist, which confers varying susceptibility to neurodegenerative and cere-
brovascular damage. Higher cognitive reserve would be reflected in a corresponding increase in tolerance for 
pathology, which has been suggested to be responsible for the discontinuity between a particular level of neuronal 
damage and clinical outcomes40. Occupational attainments, leisure activities in late life, and other sociocultural 
factors, have been suggested as key determinants of this reserve, and their effects may not be fully captured in 
the present study41. Further, differential exposure to various intrinsic (e.g. inflammation, total cholesterol) and 
extrinsic factors (e.g. nutrition, head trauma, early life stressors) has been suggested to further contribute to 
the observed cognitive disparities. This is also conceptualised in the ‘Latent Early-life Associated Regulation’ 
(LEARn) model, which posits the accumulation of epigenetic changes (specifically DNA methylation, oxidation 
and chromatin reorganization) throughout the course of life in response to various risk factors that can precipitate 
cognitive decline in late life42. Finally, other unmeasured differences in psychosocial and neuropsychological fac-
tors such as leisure activities and depression, medications, as well as other genetic polymorphisms have also been 
implicated as contributors to inter-ethnic variations in dementia43–45. Indeed, previous data from Singapore has 
identified various differences between the 3 ethnicities, some of which include an increased level of participation 
in leisure-time activities in Chinese followed by Indians and lowest in Malays, a diet consisting of the highest level 
of saturated and total fat intake with the lowest level of fruits and vegetables in Malays, as well as higher levels 
of inflammatory markers in Malays and Indians as compared to Chinese—all of which can potentially influence 
cognitive outcomes through the aforementioned mechanisms33,43,46.
Our study has a few limitations. Firstly, 40.1% of the screen-positive subjects did not agree to participate 
in phase two of the study, and a further 17.2% of the phase two subjects were excluded from the final analysis 
due to incomplete data. As mentioned before, the excluded participants were older women, with less education 
and higher burden of hypertension which may have resulted in selection bias in the current sample. Moreover, 
the exclusion of these participants may have led to an underestimation of effect sizes. However, despite this 
under-estimation, we were able to observe associations between MRI markers and ethnic groups as well as cog-
nitive impairment suggesting that the true effect sizes might be even larger. Secondly, we cannot exclude the 
possibility of complex interactions between vascular and demographic risk factors as well as residual confounding 
by other factors which were not captured in the current study. Thirdly, the cross-sectional nature of the study 
precludes temporal relationship between brain lesions and cognition.
Conclusions
In conclusion, our study showed a higher burden of cerebrovascular and neurodegenerative markers in Malays 
and Indians as compared to the Chinese, independent of other demographic and vascular risk factors. These 
markers are likely to have contributed to the poorer cognitive outcomes observed in these ethnicities, but were 
unable to fully explain the disparity. Further research is required to unravel other associated factors and pathways 
that underpin these interethnic differences which subsequently increase their susceptibility to dementia-related 
brain changes and cognitive dysfunction.
Received: 30 October 2019; Accepted: 30 January 2020;
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Figure 2. Comparison of scores on cognitive assessment between ethnicities, plotted as beta coefficients with 
95% confidence interval. Left x-axis corresponds to MMSE and MoCA scores; right x-axis corresponds to 
global cognition z-scores. Model is adjusted for age, gender, education, ApoE ɛ4 carrier status, smoking status, 
diabetes, hypertension, hyperlipidemia, BMI and all neuroimaging markers. Abbreviations – MMSE: Mini-
Mental State Examination; MoCA: Montreal Cognitive Assessment.
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